Sastravi (carbidopa levodopa entacapone): Reviews and patient testimonials

/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1564492295

Medication indications

Sastravi 100mg/25mg/200mg Film-coated Tablets

Sastravi is indicated for the treatment of adult patients with Parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (DDC) inhibitor treatment.

Sastravi 125mg/31.25mg/200mg Film-coated Tablets

Sastravi is indicated for the treatment of adult patients with Parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (DDC) inhibitor treatment.

Sastravi 150mg/37.5mg/200mg Film-coated Tablets

Sastravi is indicated for the treatment of adult patients with Parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (DDC) inhibitor treatment.

Sastravi 175mg/43.75mg/200mg Film-coated Tablets

Sastravi is indicated for the treatment of adult patients with Parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (DDC) inhibitor treatment.

Sastravi 200mg/50mg/200mg Film-coated Tablets

Sastravi is indicated for the treatment of adult patients with Parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (DDC) inhibitor treatment.

Sastravi 50mg/12.5mg/200mg Film-coated Tablets

Sastravi is indicated for the treatment of adult patients with Parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (DDC) inhibitor treatment.

Sastravi 75mg/18.75mg/200mg Film-coated Tablets

Sastravi is indicated for the treatment of adult patients with Parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (DDC) inhibitor treatment.


Route of administration: Oral
Molecule: carbidopa, levodopa, entacapone

Patients' opinions on Sastravi

In brief

General satisfaction level: 10.00/10 Learn more

Treatment's effectiveness: 10.00/10 Learn more

Ease of use: 10.00/10 Learn more

Adherence to prescription: 10.00/10 Learn more

Detected side effects: 1.00/10 Learn more

Improvement in the quality of life: 10.00/10 Learn more

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community


avatar
Osidge
on 01/04/2020

A great medication that suits my needs. 

Your message

Conditions related to this medication

Fact sheet

Parkinson's disease

See the fact sheet